FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 970008 · Received December 26, 2007

Report

Report Number
9616099-2007-02602
Event Type
Injury
Date Received
December 26, 2007
Date of Event
October 7, 2007
Report Date
November 28, 2007
Manufacturer
CORDIS DE MEXICO
Product Code
NIQ
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS DISTRIBUTED OUTSIDE THE UNITED STATES; HOWEVER IT IS SIMILAR TO THE UNITED STATES PRODUCT. THIS DEVICE IS ONE OF TWO PRODUCTS ASSOCIATED WITH THIS EVENT. PLEASE REFER TO MFT REPORT #9616099-2007-02603. THE PRODUCT REMAINS IMPLANTED IN THE PT AND IS NOT AVAILABLE FOR ANALYSIS. ADDITIONAL INFO WILL BE SUBMITTED WITHIN THIRTY DAYS UPON RECEIPT.

Description of Event or Problem · 1

THE TARGET LESION WAS A NATIVE, RESTENOTIC LESION OF A PREVIOUSLY IMPLANTED PRO-KINETIC BARE METAL STENT LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD). THE LESION WAS NON-OSTIAL, TYPE C, WITH LITTLE TO NO CALCIFICATION. THE REFERENCE VESSEL DIAMETER WAS 3.0MM AND THE LESION LENGTH WAS 18MM. PRE-PROCEDURE DIAMETER STENOSIS WAS 70%. THE LESION WAS NOT PRE-DILATED. A 3.0X33MM CYPHER SELECT PLUS STENT WAS ELECTIVELY IMPLANTED AT 22ATM. POST DILATION WAS CONDUCTED WITH A 3.0X24MM BALLOON AT 6ATM DUE TO INSUFFICIENT FLOW. A DISSECTION WAS NOTED. A 3.0X23MM CYPHER SELECT PLUS STENT WAS THEN IMPLANTED 14ATM WITH SATISFACTORY RESULT. THIS STENT WAS NOT POST-DILATED. POST-PROCEDURE DIAMETER STENOSIS WAS 10%. THREE DAYS POST PROCEDURE, THE PT FELT CHEST PAIN. CORONARY ANGIOGRAPHY SHOWED THROMBOSIS WITHIN THE IMPLANTED STENTS. PT WAS TREATED WITH INTEGRILIN AND BALLOON DILATATION. THE PT HAD ELEVATED TROPONIN T BUT NORMAL CK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DURG-ELUTING STENT (NIQ) NIQ CORDIS DE MEXICO NA UNK

Patients

Seq Age Sex Outcome Treatment
1 60 YR Life Threatening| R CLOPIDOGREL| ASPIRIN| HEPARIN